Atlas FDA

SUPARTZ FX and VISCO-3

FDA premarket approval P980044/S057 · decided 2021-08-06

Approval details

PMA number
P980044
Supplement
S057
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
SUPARTZ FX and VISCO-3
Generic name
Acid, hyaluronic, intraarticular
Applicant
Seikagaku Corp.
Date received
2021-07-21
Decision date
2021-08-06
Days to decision
16 days
Decision code
OK30
Product code
MOZ
Advisory committee
Orthopedic
Expedited review
No
Location
Tokyo
Statement
Replacement of water ultrafiltration modules.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
HADGEL, 4 GRAM/SYRINGE (K011544)Seikagaku Corp.2001-08-15